Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Tendon lengthening after achilles tendon rupture-passive effects on the ankle joint in a cadaveric pilot study simulating weight bearing.

Williamson PM, Pennings JP, Harlow E, Hanna P, Lechtig A, Okajima S, Biggane P, Nasr M, Zurakowski D, Duggal N, Nazarian A.

Injury. 2019 Oct 14. pii: S0020-1383(19)30606-0. doi: 10.1016/j.injury.2019.10.024. [Epub ahead of print]

PMID:
31685206
2.

Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis.

Blessing WA, Okajima SM, Cubria MB, Villa-Camacho JC, Perez-Viloria M, Williamson PM, Sabogal AN, Suarez S, Ang LH, White S, Flynn E, Rodriguez EK, Grinstaff MW, Nazarian A.

Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12183-12192. doi: 10.1073/pnas.1900355116. Epub 2019 Jun 3.

PMID:
31160441
3.

Diagnostic Modalities for Acute Compartment Syndrome of the Extremities: A Systematic Review.

Mortensen SJ, Vora MM, Mohamadi A, Wright CL, Hanna P, Lechtig A, Egan J, Williamson PM, Wixted JJ, Rutkove SB, Nazarian A.

JAMA Surg. 2019 Jul 1;154(7):655-665. doi: 10.1001/jamasurg.2019.1050.

PMID:
31042278
4.

Rapid urinary tract infection diagnostics by surface-enhanced Raman spectroscopy (SERS): identification and antibiotic susceptibilities.

Premasiri WR, Chen Y, Williamson PM, Bandarage DC, Pyles C, Ziegler LD.

Anal Bioanal Chem. 2017 Apr;409(11):3043-3054. doi: 10.1007/s00216-017-0244-7. Epub 2017 Feb 24.

PMID:
28235996
5.

The role of sustained release isosorbide mononitrate on corticosteroid-induced hypertension in healthy human subjects.

Williamson PM, Ong SL, Whitworth JA, Kelly JJ.

J Hum Hypertens. 2015 Dec;29(12):737-43. doi: 10.1038/jhh.2015.14. Epub 2015 Mar 26.

PMID:
25810066
6.

Decreased threshold for the nitric oxide donor glyceryl trinitrate in cortisol-induced hypertension in humans.

Kelly JJ, Tam SH, Williamson PM, Whitworth JA.

Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1317-8.

PMID:
17973874
7.

Cardiovascular consequences of cortisol excess.

Whitworth JA, Williamson PM, Mangos G, Kelly JJ.

Vasc Health Risk Manag. 2005;1(4):291-9. Review.

8.

Ganglion blockade does not prevent cortisol-induced hypertension in man.

Williamson PM, Tam SH, Kelly JJ, Whitworth JA.

Clin Exp Pharmacol Physiol. 2005 Apr;32(4):294-6.

PMID:
15810994
9.

Acute effects of hydrocortisone on plasma nitrate/nitrite activity and forearm vasodilator responsiveness in normal human subjects.

Williamson PM, Kohlhagen JL, Mangos GJ, Whitworth JA, Kelly JJ.

Clin Exp Pharmacol Physiol. 2005 Mar;32(3):162-6.

PMID:
15743397
10.

Glucocorticoids and the kidney.

Mangos GJ, Whitworth JA, Williamson PM, Kelly JJ.

Nephrology (Carlton). 2003 Dec;8(6):267-73. Review.

PMID:
15012696
11.

The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.

Hely MA, Morris JG, Traficante R, Reid WG, O'Sullivan DJ, Williamson PM.

J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):300-7.

12.

Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans.

Macefield VG, Williamson PM, Wilson LR, Kelly JJ, Gandevia SC, Whitworth JA.

Blood Press. 1998 Jul;7(4):215-22.

PMID:
9858113
13.

Cortisol and hypertension.

Kelly JJ, Mangos G, Williamson PM, Whitworth JA.

Clin Exp Pharmacol Physiol Suppl. 1998 Nov;25:S51-6. Review.

PMID:
9809193
14.

The nitric oxide system and cortisol-induced hypertension in humans.

Kelly JJ, Tam SH, Williamson PM, Lawson J, Whitworth JA.

Clin Exp Pharmacol Physiol. 1998 Nov;25(11):945-6.

PMID:
9807669
15.

Glucocorticoids and hypertension in man.

Whitworth JA, Kelly JJ, Brown MA, Williamson PM, Lawson JA.

Clin Exp Hypertens. 1997 Jul-Aug;19(5-6):871-84.

PMID:
9247761
16.

Reflex sympathetic function in cortisol-induced hypertension in humans.

Tam SH, Kelly JJ, Williamson PM, Whitworth JA.

Clin Exp Hypertens. 1997 May;19(4):479-93.

PMID:
9140709
17.

Autonomic blockade amplifies cortisol-induced hypertension in man.

Tam SH, Williamson PM, Kelly JJ, Whitworth JA.

Clin Exp Pharmacol Physiol. 1997 Jan;24(1):31-3.

PMID:
9043802
18.

Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans.

Williamson PM, Kelly JJ, Whitworth JA.

J Hypertens Suppl. 1996 Dec;14(5):S37-41.

PMID:
9120683
19.

A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia.

Reid WG, Hely MA, Morris JG, Broe GA, Adena M, Sullivan DJ, Williamson PM.

J Clin Neurosci. 1996 Oct;3(4):327-33.

PMID:
18638897
20.
21.

Age at onset: the major determinant of outcome in Parkinson's disease.

Hely MA, Morris JG, Reid WG, O'Sullivan DJ, Williamson PM, Broe GA, Adena MA.

Acta Neurol Scand. 1995 Dec;92(6):455-63.

PMID:
8750110
22.

Experimental studies on cortisol-induced hypertension in humans.

Whitworth JA, Brown MA, Kelly JJ, Williamson PM.

J Hum Hypertens. 1995 Jun;9(6):395-9. Review.

PMID:
7473517
23.

11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy.

Walker BR, Williamson PM, Brown MA, Honour JW, Edwards CR, Whitworth JA.

Hypertension. 1995 Apr;25(4 Pt 1):626-30.

PMID:
7721407
24.

Mechanisms of cortisol-induced hypertension in humans.

Whitworth JA, Brown MA, Kelly JJ, Williamson PM.

Steroids. 1995 Jan;60(1):76-80. Review.

PMID:
7792821
25.

The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.

Hely MA, Morris JG, Reid WG, O'Sullivan DJ, Williamson PM, Rail D, Broe GA, Margrie S.

J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):903-10.

26.

Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment.

Whitworth JA, Williamson PM, Brown MA, Edwards CR.

Clin Exp Hypertens. 1994 Jul;16(4):431-50.

PMID:
7920454
27.

Hyperinsulinemia is not a cause of cortisol-induced hypertension.

Whitworth JA, Williamson PM, Brown MA, Colman P.

Am J Hypertens. 1994 Jun;7(6):562-5.

PMID:
7917157
28.

Neuropeptide Y in cortisol-induced hypertension in male volunteers.

Whitworth JA, Williamson PM, Brown MA, Morris MJ.

Clin Exp Pharmacol Physiol. 1994 May;21(5):435-8.

PMID:
7955553
29.

Reliability of the Columbia scale for assessing signs of Parkinson's disease.

Hely MA, Chey T, Wilson A, Williamson PM, O'Sullivan DJ, Rail D, Morris JG.

Mov Disord. 1993 Oct;8(4):466-72.

PMID:
8232356
30.

Effects of cortisol on blood pressure and salt preference in normal humans.

Wong KS, Williamson PM, Brown MA, Zammit VC, Denton DA, Whitworth JA.

Clin Exp Pharmacol Physiol. 1993 Feb;20(2):121-6.

PMID:
8443975
31.

Haemodynamic and metabolic effects of short term administration of synthetic sex steroids in humans.

Whitworth JA, Scoggins BA, Andrews J, Williamson PM, Brown MA.

Clin Exp Hypertens A. 1992;14(5):905-22.

PMID:
1395077
32.

Nystagmus retractorius and progressive ataxia in a young man: clinicopathological conference.

Zagami AS, Williamson PM, Yong JL, Jones PD.

Med J Aust. 1990 Oct 1;153(7):422-8. No abstract available.

PMID:
2215315
33.

The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset.

Reid WG, Broe GA, Hely MA, Morris JG, Williamson PM, O'Sullivan DJ, Rail D, Genge S, Moss NG.

Int J Neurosci. 1989 Oct;48(3-4):205-17.

PMID:
2583935
34.

The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.

Hely MA, Morris JG, Rail D, Reid WG, O'Sullivan DJ, Williamson PM, Genge S, Broe GA.

J Neurol Neurosurg Psychiatry. 1989 Mar;52(3):324-8.

35.

The Sydney multicentre study of Parkinson's disease. The first 18 months.

Hely MA, Morris JG, Rail D, O'Sullivan DJ, Williamson PM, Genge S, Reid WG, Broe GA.

Med J Aust. 1987 Feb 16;146(4):195-8.

PMID:
3553878
36.

Neurological complications of Mycoplasma pneumoniae infection.

Hely MA, Williamson PM, Terenty TR.

Clin Exp Neurol. 1984;20:153-60.

PMID:
6439446
37.

Prescribing restriction: implications and reactions.

Wolfson DJ, Williamson PM.

Drug Intell Clin Pharm. 1981 Jul-Aug;15(7-8):594-7.

PMID:
7249934
38.

Progressive multifocal leucoencephalopathy: CT and pathological features.

Durham DS, Fryer JA, O'Neill BJ, Williamson PM.

Med J Aust. 1980 Nov 1;2(9):502-4.

PMID:
6894180
39.

Hypercalcaemia associated with cerebral vasospasm causing infarction.

Walker GL, Williamson PM, Ravich RB, Roche J.

J Neurol Neurosurg Psychiatry. 1980 May;43(5):464-7.

40.

Association of central nervous system sarcoma with familial polyposis coli.

Williamson PM, Smith KV.

Clin Exp Neurol. 1978;15:127-30.

PMID:
386305
41.

Syndrome of ophthalmoplegia, ataxia and areflexia.

Storey CE, Selby G, Williamson PM.

Clin Exp Neurol. 1977;14:75-82.

PMID:
616611
42.

How general practitioners assess risks in using new drugs.

Williamson PM.

J R Coll Gen Pract. 1975 May;25(154):383-6.

43.

The adoption of new drugs by doctors practising in group and solo practice.

Williamson PM.

Soc Sci Med. 1975 Apr-May;9(4-5):233-6. No abstract available.

PMID:
1154044
44.

Neuromyelitis optica following infectious mononucleosis.

Williamson PM.

Proc Aust Assoc Neurol. 1975;12:153-5.

PMID:
1215384
45.

Subacute spongioform encephalopathy--a clinical and pathological study with attention to liver involvement.

Williamson PM, Payne WH, Selby G, Davis E.

Proc Aust Assoc Neurol. 1973;9:111-9. No abstract available.

PMID:
4578244

Supplemental Content

Loading ...
Support Center